FDA will phase out 22 Covid-19 guid­ance doc­u­ments as emer­gency de­c­la­ra­tion ex­pires

With the pub­lic health emer­gency and the na­tion­al emer­gency de­c­la­ra­tion ex­pect­ed to ex­pire on May 11, the FDA will be let­ting some guid­ance doc­u­ments ex­pire along with it.

In a doc­u­ment pub­lished Fri­day in the Fed­er­al Reg­is­ter, the FDA said that of the 72 Covid-19 guid­ances that are still ac­tive, 22 will no longer be in ef­fect when the de­c­la­ra­tions ex­pire.

Those guid­ance docs that are be­ing cut, and which typ­i­cal­ly of­fered some le­nien­cy from the FDA due to the con­straints of the pan­dem­ic, in­clude ones re­lat­ed to man­u­fac­tur­ing con­sid­er­a­tions for cell and gene ther­a­pies, non­hu­man pri­mate sup­ply con­straints, sta­tis­ti­cal con­sid­er­a­tions for clin­i­cal tri­als and more.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER